Photo via South China Morning Post

Spirit of Hong Kong Awards: biotech firm eyes cervical cancer test breakthrough

Read the original at South China Morning Post ↗
Cite

Chow, J. (2026, October 11). Spirit of Hong Kong Awards: biotech firm eyes cervical cancer test breakthrough. South China Morning Post. https://www.scmp.com/news/hong-kong/society/article/3370459/spirit-hong-kong-awards-biotech-firm-eyes-cervical-cancer-test-breakthrough?utm_source=rss_feed

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

South China Morning Post · collected 2026-10-11 · by Jimmy Chow

Quick Summary

Ricky Chiu Yin-to, founder of Hong Kong biotech firm Phase Scientific, aims to develop an easier method for cervical cancer screening using urine-based HPV tests. During the pandemic, his company became known for its Indicaid rapid antigen test, which received US emergency-use authorization in July 2021 and was used extensively both locally and internationally. The company's workforce grew from 20-30 employees to a peak of around 400 during the pandemic, with monthly production reaching up to 30 million tests. Chiu plans to use the resources gained during this period to advance research on early cancer detection methods.
Written by AI on 2026-10-11, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

Ricky Chiu Yin-to, founder of Phase Scientific, is developing a urine-based HPV test to make cervical cancer screening more accessible. This builds on the company's success during the pandemic with its Indicaid rapid antigen test, which received US emergency-use authorization in July 2021 and was widely used in Hong Kong and internationally.

During the peak of the pandemic, Phase Scientific grew from employing around 20 to 30 people to having a workforce of up to 400. The company produced as many as 30 million rapid tests per month during this period. Chiu plans to use the funds and technological advancements gained during the pandemic to further develop long-term research initiatives, such as the cervical cancer test.

Written for “Hong Kong Biotech Breakthrough” on 2026-11-02, grounded in this article and the 0 other(s) covering the same event.

Story

📰 Hong Kong Biotech Breakthrough
Science · 1 article(s) covering the same event.

Compared with similar articles

Nothing to compare against. No article is close enough to this one for the pipeline to have linked or judged the pair.
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
7
sentences that state something as happening or true
Uncertain
0%
0 of 7 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
63/100
South China Morning Post's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Science
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-10-11 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

South China Morning Post · 3608 article(s) · 7 correction(s) detected
Running correction rate · 7 correction(s)

Who wrote this

Jimmy Chow
25 article(s) here · 0 carrying a prediction
🔮 Alfred Lam says helping elderly people and disadvantaged communities allows him to look beyond symptoms and understand those he may one day treat Years of volunteering to serve elderly people and disadvantaged communities have informed medical student Alfred Lam’s approach to medicine, teaching the University of Hong Kong undergraduate to look beyond symptoms and understand the people he may one day treat. Lam is a finalist in the youth category of this year’s Spirit of Hong Kong Awards, which recognise the city’s unsung heroes and organisations whose work might otherwise escape public attention.
🔮 Claudia Chan Shu-ying, a medical student at the Chinese University of Hong Kong (CUHK), is developing CancerCompanion, a digital companion designed to offer emotional support between appointments, including late at night when professional help may not be immediately available.
🔮 Founded in 2014, the organisation helps people who may not qualify for legal aid or cannot afford private representation.
🔮 Spirit of Hong Kong Awards finalist Dr Ng Kwai-lun provides transparent funeral care and end-of-life planning through his social enterprise After years of teaching Hongkongers about death and end-of-life arrangements, Dr Ng Kwai-lun realised there was a gap between what people were told they could do and the services actually available to them.
🔮 Dream Compassioneers co-founder Chan Yik-yeung said the response also showed what students could achieve when trusted with responsibility.
🔮 Born with a hearing impairment, Fung struggled with language subjects at school because he could not always hear clearly.
🔮 Mahtani, founder of OCD & Anxiety Support Hong Kong, said better referrals between hospitals, community mental health services and specialist charities could help people receive timely support while they wait for formal treatment.
🔮 “If I had given up after losing six scholarship opportunities, I would not be here in Hong Kong teaching today,” he said.
🔮 She heard the applause but could not see who it came from.
Also by Jimmy Chow
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 25 articles by Jimmy Chow →

Topics

Hong Kong Indicaid Phase Scientific

Subjects

Hong Kong GPE · 2× Phase Scientific ORG · 2× Chiu PERSON · 1× Ricky Chiu PERSON · 1× Ricky Chiu Yin-to PERSON · 1×

Narrative

Phase Scientific founder Ricky Chiu is drawing on his firm’s pandemic experience to advance early detection methods through urine-based HPV testing Hong Kong biotech entrepreneur Ricky Chiu Yin-to is seeking to make cervical cancer screening easier through urine-based HPV testing, using sample-concentration technology developed by his company.
framing: assertive · carried by 1 article(s) · first seen 2026-10-11
2026-10-11 · South China Morning Post
Spirit of Hong Kong Awards: biotech firm eyes cervical cancer test breakthrough · assertive framing

Claims (7 extracted, 0 hedged)

biotech firm eyes cervical cancer test breakthrough asserted
firm → eye → breakthrough
Phase Scientific founder Ricky Chiu is drawing on his firm’s pandemic experience to advance early detection methods through urine-based HPV testing Hong Kong biotech entrepreneur Ricky Chiu Yin-to is seeking to make cervical cancer screening easier through urine-based HPV testing, using sample-concentration technology developed by his company. asserted
screening → draw → company
His company, Phase Scientific, made its name during the Covid-19 pandemic through its rapid antigen test, Indicaid. asserted
company → make → test
The product received US emergency-use authorisation in July 2021, was used in Hong Kong community testing and sold in more than 30 countries. asserted
product → receive → countries
At the start of the pandemic, the firm employed 20 to 30 people. asserted
firm → employ → people
Its headcount later peaked at around 400, while monthly production reached as many as 30 million rapid tests. asserted
production → peak → tests
Chiu said business during the pandemic gave the company the funds, manufacturing experience, team and technology to pursue longer-term research after demand for rapid testing subsided. asserted
demand → say → testing
💬Give feedback
🕘History 🎫Support